Welcome BOC, Thats an impossible question to answer at this point in time... It will be many multiples of current SP if they get FDAs Approval as you asked. Of all the Life Sciences Companies on our ASX, there reallyare only a few that are outstanding... COH SIR are two that have shone.. Have a look at their long term charts to see the possibilities..
Of the smaller emerging Biotchs, NEU is outstanding.. This company ticks every box... Management, Science, Cash, Prduct Development, Market Targets.. If you have a really good hunt around , I doubt if you can find another emerging company thats got it all....
The success that COH RMD CSL RMD have had is a strong possibilty here... Because they tick all of the boxes.. Not just 7 out of 10 or even 9 out of 10..
Caution this takes time, it won't happen overnight..
Long term price target, page-2
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.38 |
Change
-0.270(1.98%) |
Mkt cap ! $1.710B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.11 | $4.283M | 320.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $13.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.40 | 3328 | 3 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |